Repligen Corporation has acquired BioLife Solutions, Inc. for $0 USD. The transaction was reported on October 9, 2026.
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy market. Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems for manufacturing biological drugs. The company's focus areas include Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins, serving biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.
According to Goodwin, BioLife is expected to benefit from Repligen’s global reach, including Asia Pacific, while Repligen is expected to benefit from BioLife’s customer relationships.